Main > ONCOLOGY (**) > Leukemia>Myeloid>Acute>IDH1+ R/R > Treatment > FR. S. Ivosidenib 250 mg Tab. > Companion Diagnostics>
Companion Diagnostics>'s subsections
>Company
>TradeMark
>USA Approval Date: 2018. 07.20
>USA Launch Date: 2018. 07.27.
>USA Launched By:
Companion Diagnostics>'s products
This section has no products